Department of Experimental Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands.
Department of General Practice and Elderly Care Medicine, Amsterdam University Medical Center, Amsterdam, the Netherlands.
Diabetologia. 2023 Mar;66(3):482-494. doi: 10.1007/s00125-022-05826-y. Epub 2022 Nov 8.
AIMS/HYPOTHESIS: Both manifestations of kidney disease in diabetes, reduced eGFR (ml/min per 1.73 m) and increased urinary albumin/creatinine ratio (UACR, mg/mmol), may increase the risk of specific CVD subtypes in adults with diabetes.
We assessed the prospective association between annually recorded measures of eGFR and UACR and the occurrence of myocardial infarction (MI), CHD, stroke, heart failure (HF) and cardiovascular mortality in 13,657 individuals with diabetes (53.6% male, age 62.3±12.1 years) from the Hoorn Diabetes Care System cohort, using data obtained between 1998 and 2018. Multivariate time-dependent Cox regression models adjusted for cardiovascular risk factors were used to estimate HRs and 95% CI. Associations of eGFR were adjusted for UACR values and vice versa. Effect modification by sex was investigated for all associations.
After a mean follow-up period of 7 years, event rates per 1000 person-years were 3.08 for MI, 3.72 for CHD, 1.12 for HF, 0.84 for stroke and 6.25 for cardiovascular mortality. Mildly reduced eGFR (60-90 ml/min per 1.73 m) and moderately to severely reduced eGFR (<59 ml/min per 1.73 m) were associated with higher risks of MI (HR 1.52; 95% CI 1.10, 2.12 and HR 1.69; 95% CI 1.09, 2.64) and CHD (HR 1.67; 95% CI 1.23, 2.26 and HR 2.01; 95% CI 1.34, 3.02) compared with normal eGFR (>90 ml/min per 1.73 m). Mildly reduced eGFR was associated with a higher risk of stroke (HR 2.53; 95% CI 1.27, 5.03). Moderately increased UACR (3-30 mg/mmol) and severely increased UACR (>30 mg/mmol) were prospectively associated with a higher cardiovascular mortality risk in men and women (HR 1.87; 95% CI 1.41, 2.47 and HR 2.78; 95% CI 1.78, 4.34) compared with normal UACR (<3 mg/mmol). Significant effect modification by sex was observed for the association between UACR and HF. Because there were a limited number of HF events within the category of UACR >30 mg/mmol, categories were combined into UACR <3.0 and >3.0 mg/mmol in the stratified analysis. Women but not men with UACR >3.0 mg/mmol had a significantly higher risk of HF compared with normal UACR (HR 2.79; 95% CI 1.47, 5.28).
CONCLUSIONS/INTERPRETATION: This study showed differential and independent prospective associations between manifestations of early kidney damage in diabetes and several CVD subtypes, suggesting that regular monitoring of both kidney function measures may help to identify individuals at higher risk of specific cardiovascular events.
目的/假设:糖尿病患者的肾脏疾病表现(肾小球滤过率[eGFR]降低[ml/min/1.73m]和尿白蛋白/肌酐比值[UACR]升高[mg/mmol])可能会增加成年糖尿病患者特定心血管疾病(CVD)亚型的风险。
我们评估了在 Hoorn 糖尿病护理系统队列中,13657 名患有糖尿病的个体(53.6%为男性,年龄 62.3±12.1 岁)中,每年记录的 eGFR 和 UACR 与心肌梗死(MI)、冠心病(CHD)、中风、心力衰竭(HF)和心血管死亡率之间的前瞻性关联,数据获取时间为 1998 年至 2018 年。使用多变量时间依赖性 Cox 回归模型,根据心血管危险因素对 HR 和 95%CI 进行了调整。eGFR 的相关性调整了 UACR 值,反之亦然。对于所有关联,我们都研究了性别对效应修饰的影响。
在平均 7 年的随访期间,每 1000 人年的事件发生率为 MI 3.08 例、CHD 3.72 例、HF 1.12 例、中风 0.84 例和心血管死亡率 6.25 例。轻度降低的 eGFR(60-90 ml/min/1.73m)和中度至重度降低的 eGFR(<59 ml/min/1.73m)与 MI(HR 1.52;95%CI 1.10,2.12 和 HR 1.69;95%CI 1.09,2.64)和 CHD(HR 1.67;95%CI 1.23,2.26 和 HR 2.01;95%CI 1.34,3.02)的风险增加相关,而正常 eGFR(>90 ml/min/1.73m)相比。轻度降低的 eGFR 与中风风险增加(HR 2.53;95%CI 1.27,5.03)相关。UACR 中度增加(3-30 mg/mmol)和严重增加(>30 mg/mmol)与男性和女性的心血管死亡率风险增加相关(HR 1.87;95%CI 1.41,2.47 和 HR 2.78;95%CI 1.78,4.34),与正常 UACR(<3 mg/mmol)相比。UACR 与 HF 之间的关联存在显著的性别效应修饰。由于 UACR >30 mg/mmol 类别中 HF 事件的数量有限,因此在分层分析中将类别合并为 UACR <3.0 和>3.0 mg/mmol。与正常 UACR 相比,UACR >3.0 mg/mmol 的女性而非男性 HF 的风险显著增加(HR 2.79;95%CI 1.47,5.28)。
结论/解释:本研究表明,糖尿病早期肾脏损害的表现与几种 CVD 亚型之间存在差异和独立的前瞻性关联,表明定期监测肾功能指标可能有助于识别特定心血管事件风险较高的个体。